MD PhD with focus in oncoimmunology.Over 10 years of experience in the pharmaceutical industry.
18.11.20 Pfizer/BioNTech claim 95% efficacy (94% in 65 years of age population) for their mRNA vaccine candidate.
16.11.20 Moderna claims 94% efficacy for its mRNA vaccine candidate.